Leaderer et al. have reported the decreased methylation in the CpG island spanning the promoter region, the first exon, and part of the first intron of the XPO5 gene (−600 to 808), which may explain why XPO5 expression is upregulated in breast cancer [25]. This evidence concerns the gene XPO5 and breast carcinoma.